Antibiotic use and emerging resistance: How can resource-limited countries turn the tide?

Global Heart

Volumn 9, Issue 3, 2014, Pages 347-358

  Bebell, Lisa M ^a   Muiru, Anthony N ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; CLINICAL DECISION MAKING; DRUG USE; HAND WASHING; HEALTHCARE ASSOCIATED INFECTION; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; CROSS INFECTION; DRUG UTILIZATION; FORECASTING; HEALTH; HEALTH CARE PLANNING; STANDARDS; STATISTICS AND NUMERICAL DATA;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; DRUG UTILIZATION; FORECASTING; GLOBAL HEALTH; HAND HYGIENE; HEALTH RESOURCES; HUMANS; PUBLIC HEALTH;

EID: 84927610352     PISSN: 22118160     EISSN: 22118179     Source Type: Journal    
DOI: 10.1016/j.gheart.2014.08.009     Document Type: Review

References (105)

1. Col NF, O'Connor RW. Estimating worldwide current antibiotic usage: Report of Task Force 1. Rev Infect Dis 1987; 9(Suppl 3): S232-43.
2. Hardin G. The tragedy of the commons: The population problem has no technical solution; it requires a fundamental extension in morality. Science 1968; 162: 1243-8.
3. Talukdar PK, Rahman M, Rahman M, et al. Antimicrobial resistance, virulence factors and genetic diversity of Escherichia coli isolates from household water supply in Dhaka, Bangladesh. PLoS One 2013; 8: E61090.
4. Figueira V, Serra EA, Vaz-Moreira I, Brandão TR, Manaia CM. Comparison of ubiquitous antibiotic-resistant Enterobacteriaceae populations isolated from wastewaters, surface waters and drinking waters. J Water Health 2012; 10: 1-10.
5. Coleman BL, Salvadori MI, McGeer AJ, et al. The role of drinking water in the transmission of antimicrobial-resistant E. coli. Epidemiol Infect 2012; 140: 633-42.
6. Garcia-Migura L, Hendriksen RS, Fraile L, Aarestrup FM. Antimicrobial resistance of zoonotic and commensal bacteria in Europe: The missing link between consumption and resistance in veterinary medicine. Vet Microbiol 2014; 170: 1-9.
7. Oluyege JO, Dada AC, Odeyemi AT. Incidence of multiple antibiotic resistant Gram-negative bacteria isolated from surface and underground water sources in south western region of Nigeria. Water Sci Technol 2009; 59: 1929-36.
8. Coleman BL, Louie M, Salvadori MI, et al. Contamination of Canadian private drinking water sources with antimicrobial resistant Escherichia coli. Water Res 2013; 47: 3026-36.
9. Jiang X, Yu T,Wu N, Meng H, Shi L. Detection of qnr, aac(6')-Ib-cr and qepA genes in Escherichia coli isolated from cooked meat products in Henan, China. Int J Food Microbiol 2014; 187: 22-5.
10. Vogt D, Overesch G, Endimiani A, Collaud A, Thomann A, Perreten V. Occurrence and genetic characteristics of third-generation cephalosporin- resistant Escherichia coli in Swiss retail meat. Microb Drug Resist 2014; 20: 485-94.
11. Abgottspon H, Stephan R, Bagutti C, Brodmann P, Hachler H, Zurfluh K. Characteristics of extended-spectrum cephalosporinresistant Escherichia coli isolated from Swiss and imported poultry meat. J Food Prot 2014; 77: 112-5.
12. Jana A, Mondal A. Serotyping, pathogenicity and antibiogram of Escherichia coli isolated from raw poultry meat in West Bengal, India. Vet Ital 2013; 49: 361-5.
13. Ingram PR, Rogers BA, Sidjabat HE, Gibson JS, Inglis TJ. Co-selection may explain high rates of ciprofloxacin non-susceptible Escherichia coli from retail poultry reared without prior fluoroquinolone exposure. J Med Microbiol 2013; 62: 1743-6.
14. Stevenson KB, Balada-Llasat JM, Bauer K, et al. The economics of antimicrobial stewardship: The current state of the art and applying the business case model. Infect Control Hosp Epidemiol 2012; 33: 389-97.
15. Dellit TH, Owens RC, McGowan JE Jr., et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007; 44: 159-77.
16. McGowan JE Jr. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 1983; 5: 1033-48.
17. Courcol RJ, Pinkas M, Martin GR. A seven year survey of antibiotic susceptibility and its relationship with usage. J Antimicrob Chemother 1989; 23: 441-51.
18. Seppala H, Klaukka T, Vuopio-Varkila J, et al., for the Finnish Study Group for Antimicrobial Resistance. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med 1997; 337: 441-6.
19. Muller AA, Mauny F, Bertin M, et al. Relationship between spread of methicillin-resistant Staphylococcus aureus and antimicrobial use in a French university hospital. Clin Infect Dis 2003; 36: 971-8.
20. Chancey ST, Zähner D, Stephens DS. Acquired inducible antimicrobial resistance in Gram-positive bacteria. Future Microbiol 2012; 7: 959-78.
21. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrugresistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18: 268-81.
22. Tenover FC. Mechanisms of antimicrobial resistance in bacteria. Am J Infect Control 2006; 34(Suppl 1): S3-10. discussion S64e73.
23. Widdowson CA, Klugman KP. Molecular mechanisms of resistance to commonly used non-betalactam drugs in Streptococcus pneumoniae. Semin Respir Infect 1999; 14: 255-68.
24. Labby KJ, Garneau-Tsodikova S. Strategies to overcome the action of aminoglycoside-modifying enzymes for treating resistant bacterial infections. Future Med Chem 2013; 5: 1285-309.
25. Tupin A, Gualtieri M, Roquet-Banères F, Morichaud Z, Brodolin K, Leonetti JP. Resistance to rifampicin: At the crossroads between ecological, genomic and medical concerns. Int J Antimicrob Agents 2010; 35: 519-23.
26. Rossolini GM, Mantengoli E, Montagnani F, Pollini S. Epidemiology and clinical relevance of microbial resistance determinants versus anti-Gram-positive agents. Curr Opin Microbiol 2010; 13: 582-8.
27. Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: A molecular, biological, and epidemiological study. Lancet Infect Dis 2010; 10: 597-602.
28. Hede K. Antibiotic resistance: An infectious arms race. Nature 2014; 509: S2-3.
29. World Health Organization. Antimicrobial Resistance: Global Report on Surveillance. Geneva, Switzerland: WHO Press; 2014.
30. CDC. Types of Healthcare-Associated Infections. Atlanta, GA: Centers for Disease Control and Prevention; 2014.
31. Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990e2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2197-223.
32. Allegranzi B, Bagheri Nejad S, et al. Burden of endemic healthcare- Associated infection in developing countries: Systematic review and meta-analysis. Lancet 2011; 377: 228-41.
33. Burke JP. Infection control-A problem for patient safety. N Engl J Med 2003; 348: 651-6.
34. Bates DW, Larizgoitia I, Prasopa-Plaizier N, et al., for the Research Priority Setting Working Group of the WHO World Alliance for Patient Safety. Global priorities for patient safety research. BMJ 2009; 338: B1775.
35. Pittet D, Allegranzi B, Storr J, Donaldson L. "Clean Care is Safer Care": The Global Patient Safety Challenge 2005e2006. Int J Infect Dis 2006; 10: 419-24.
36. Okeke IN, Laxminarayan R, Bhutta ZA, et al. Antimicrobial resistance in developing countries. Part I: Recent trends and current status. Lancet Infect Dis 2005; 5: 481-93.
37. Rhomberg PR, Fritsche TR, Sader HS, Jones RN. Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA). Diagn Microbiol Infect Dis 2006; 56: 57-62.
38. Lin MY, Hayden MK. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: Recognition and prevention in intensive care units. Crit Care Med 2010; 38(Suppl 8): S335-44.
39. Zarrilli R, Giannouli M, Tomasone F, Triassi M, Tsakris A. Carbapenem resistance in Acinetobacter baumannii: The molecular epidemic features of an emerging problem in health care facilities. J Infect Dev Ctries 2009; 3: 335-41.
40. Wattal C, Goel N, Oberoi JK, Raveendran R, Datta S, Prasad KJ. Surveillance of multidrug resistant organisms in tertiary care hospital in Delhi, India. J Assoc Physicians India 2010; 58(Suppl): 32-6.
41. Daneman N, Sarwar S, Fowler RA, et al., for the SuDDICU Canadian Study Group. Effect of selective decontamination on antimicrobial resistance in intensive care units: A systematic review and metaanalysis. Lancet Infect Dis 2013; 13: 328-41.
42. Madani N, Rosenthal VD, Dendane T, Abidi K, Zeggwagh AA, Abouqal R. Health-care associated infections rates, length of stay, and bacterial resistance in an intensive care unit of Morocco: Findings of the International Nosocomial Infection Control Consortium (INICC). Int Arch Med 2009; 2: 29.
43. Leblebicioglu H, Rosenthal VD, Arikan OA, et al., for the Turkish Branch of INICC. Device-associated hospital-acquired infection rates in Turkish intensive care units: Findings of the International Nosocomial Infection Control Consortium (INICC). J Hosp Infect 2007; 65: 251-7.
44. Zaidi AK, Huskins WC, Thaver D, Bhutta ZA, Abbas Z, Goldmann DA. Hospital-acquired neonatal infections in developing countries. Lancet 2005; 365: 1175-88.
45. Waters D, Jawad I, Ahmad A, et al. Aetiology of community-acquired neonatal sepsis in low and middle income countries. J Glob Health 2011; 1: 154-70.
46. Viswanathan R, Singh AK, Ghosh C, Dasgupta S, Mukherjee S, Basu S. Profile of neonatal septicaemia at a district-level sick newborn care unit. J Health Popul Nutr 2012; 30: 41-8.
47. Pollock MR. Origin and function of penicillinase: A problem in biochemical evolution. Br Med J 1967; 4: 71-7.
48. World Health Organization. The World Medicines Situation 2011. Geneva, Switzerland: The World Health Organization; 2011.
49. Ruppé E, Armand-Lefèvre L, Estellat C, et al. Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013. Euro Surveill 2014; 19. pii: 20768.
50. CDC. Vital signs: Carbapenem-resistant Enterobacteriaceae. MMWR Morb Mortal Wkly Rep 2013; 62: 165-70.
51. McNeil DG Jr. Antibiotic-resistant bacteria moving from South Asia to U.S. New York Times. August 11, 2010. Available at: Http://www. nytimes.com/2010/08/12/world/asia/12bug.html?-r=0.
52. Nordmann P. Carbapenemase-producing Enterobacteriaceae: Overview of a major public health challenge. Med Mal Infect 2014; 44: 51-6.
53. Hudson CM, Bent ZW, Meagher RJ, Williams KP. Resistance determinants and mobile genetic elements of an NDM-1-encoding Klebsiella pneumoniae strain. PLoS One 2014; 9: E99209.
54. Islam MA, Nabi A, Rahman M, et al. Prevalence of faecal carriage of NDM-1-producing bacteria among patients with diarrhoea in Bangladesh. J Med Microbiol 2014; 63: 620-2.
55. Guerra B, Fischer J, Helmuth R. An emerging public health problem: Acquired carbapenemase-producing microorganisms are present in food-producing animals, their environment, companion animals and wild birds. Vet Microbiol 2014; 171: 290-7.
56. Singer RS, Finch R, Wegener HC, Bywater R, Walters J, Lipsitch M. Antibiotic resistance-The interplay between antibiotic use in animals and human beings. Lancet Infect Dis 2003; 3: 47-51.
57. Walsh TR, Weeks J, Livermore DM, Toleman MA. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: An environmental point prevalence study. Lancet Infect Dis 2011; 11: 355-62.
58. Stelling JM, Travers K, Jones RN, Turner PJ, O'Brien TF, Levy SB. Integrating Escherichia coli antimicrobial susceptibility data from multiple surveillance programs. Emerg Infect Dis 2005; 11: 873-82.
59. Lester SC, del Pilar Pla M, Wang F, Perez Schael I, Jiang H, O'Brien TF. The carriage of Escherichia coli resistant to antimicrobial agents by healthy children in Boston, in Caracas, Venezuela, and in Qin Pu, China. N Engl J Med 1990; 323: 285-9.
60. Alliance for the Prudent Use of Antibiotics. Executive summary: Select findings, conclusions, and policy recommendations. Clin Infect Dis 2005; 41(Suppl 4): S224-7.
61. Bartoloni A, Pallecchi L, Benedetti M, et al. Multidrug-resistant commensal Escherichia coli in children, Peru and Bolivia. Emerg Infect Dis 2006; 12: 907-13.
62. Reardon S. Antibiotic resistance sweeping developing world. Nature 2014; 509: 141-2.
63. Okeke IN, Edelman R. Dissemination of antibiotic-resistant bacteria across geographic borders. Clin Infect Dis 2001; 33: 364-9.
64. Rosenthal VD, Maki DG, Jamulitrat S, et al., for the INICC Members. International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003e2008, issued June 2009. Am J Infect Control 2010; 38: 95-104.e2.
65. WHO. The World Health Report 2006-Working Together for Health. Geneva, Switzerland: World Health Organization; 2006.
66. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095-128.
67. Leung E, Weil DE, Raviglione M, et al., for the World Health Organization World Health Day Antimicrobial Resistance Technical Working Group. The WHO policy package to combat antimicrobial resistance. Bull World Health Organ 2011; 89: 390-2.
68. WHO. WHO Global Strategy for Containment of Antimicrobial Resistance. Geneva, Switzerland: World Health Organization; 2001.
69. Holloway K, Mathai E, Gray A, for the Community-Based Surveillance of Antimicrobial Use and Resistance in Resource-Constrained Settings Project Group. Surveillance of antimicrobial resistance in resource-constrained settings-experience from five pilot projects. Trop Med Int Health 2011; 16: 368-74.
70. Nguyen KV, Thi Do NT, Chandna A, et al. Antibiotic use and resistance in emerging economies: A situation analysis for Viet Nam. BMC Public Health 2013; 13: 1158.
71. Rosenthal VD, Todi SK, Álvarez-Moreno C, Pawar M, et al., for the INICC Members. Impact of a multidimensional infection control strategy on catheter-associated urinary tract infection rates in the adult intensive care units of 15 developing countries: Findings of the International Nosocomial Infection Control Consortium (INICC). Infection 2012; 40: 517-26.
72. Rosenthal VD, Bijie H, Maki DG, et al. International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004e2009. Am J Infect Control 2012; 40: 396-407.
73. Rosenthal VD, Pawar M, Leblebicioglu H, et al. Impact of the International Nosocomial Infection Control Consortium (INICC) multidimensional hand hygiene approach over 13 years in 51 cities of 19 limited-resource countries from Latin America, Asia, the Middle East, and Europe. Infect Control Hosp Epidemiol 2013; 34: 415-23.
74. WHO. Country Pharmaceutical Situations. Geneva, Switzerland: World Health Organization; 2009.
75. WHO. Medicines Use in Primary Care in Developing and Transitional Countries. Geneva, Switzerland: World Health Organization; 2009.
76. Goossens H. Antibiotic consumption and link to resistance. Clin Microbiol Infect 2009; 15(Suppl 3): 12-5.
77. WHO. Using Indicators to Measure Country Pharmaceutical Situations: Fact Book on WHO Level I and Level II Monitoring Indicator. Geneva, Switzerland: World Health Organization; 2006.
78. Bavestrello L, Cabello A, Casanova D. [Impact of regulatory measures in the trends of community consumption of antibiotics in Chile]. Rev Med Chil 2002; 130: 1265-72 [in Spanish].
79. Okeke IN, Peeling RW, Goossens H, et al. Diagnostics as essential tools for containing antibacterial resistance. Drug Resist Updat 2011; 14: 95-106.
80. Berkelman R, Cassell G, Specter S, Hamburg M, Klugman K. The "Achilles heel" of global efforts to combat infectious diseases. Clin Infect Dis 2006; 42: 1503-4.
81. Dryden MS, Cooke J, Davey P. Antibiotic stewardship-more education and regulation not more availability? J Antimicrob Chemother 2009; 64: 885-8.
82. Seale AC, Mwaniki M, Newton CR, Berkley JA. Maternal and early onset neonatal bacterial sepsis: Burden and strategies for prevention in Sub-Saharan Africa. Lancet Infect Dis 2009; 9: 428-38.
83. Nuzzo JB, Rambhia KJ, Wollner SB, et al. Diagnostics for Global Biosurveillance: Turning Promising Science into the Tools Needed in the Field. Center for Biosecurity of UPMC; September 13, 2011. Available at: Http://www.upmchealthsecurity.org/our-work/pubs-archive/pubs-pdfs/2011/2011-09-13-global-biosurveillance-DTRA.pdf.
84. Caliendo AM, Gilbert DN, Ginocchio CC, et al., for the Infectious Diseases Society of America. Better tests, better care: Improved diagnostics for infectious diseases. Clin Infect Dis 2013; 57(Suppl 3): S139-70.
85. Lubell Y, Reyburn H, Mbakilwa H, et al. The cost-effectiveness of parasitologic diagnosis for malaria-suspected patients in an era of combination therapy. Am J Trop Med Hyg 2007; 77: 128-32.
86. Bell D, Perkins MD. Making malaria testing relevant: Beyond test purchase. Trans R Soc Trop Med Hyg 2008; 102: 1064-6.
87. Iffy L. Contribution of Semmelweis to problem of puerperal fever. Am J Obstet Gynecol 1968; 102: 1180-1.
88. Nguyen D, MacLeod WB, Phung DC, et al. Incidence and predictors of surgical-site infections in Vietnam. Infect Control Hosp Epidemiol 2001; 22: 485-92.
89. Allegranzi B, Sax H, Bengaly L, et al., for the World Health Organization "Point G" Project Management Committee. Successful implementation of the World Health Organization hand hygiene improvement strategy in a referral hospital in Mali, Africa. Infect Control Hosp Epidemiol 2010; 31: 133-41.
90. Rosenthal VD, McCormick RD, Guzman S, Villamayor C, Orellano PW. Effect of education and performance feedback on handwashing: The benefit of administrative support in Argentinean hospitals. Am J Infect Control 2003; 31: 85-92.
91. Rosenthal VD, Maki DG, Salomao R, et al., International Nosocomial Infection Control Consortium. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med 2006; 145: 582-91.
92. Barahona-Guzmán N, Rodriguez-Calderón ME, Rosenthal VD, et al. Impact of the International Nosocomial Infection Control Consortium (INICC) multidimensional hand hygiene approach in three cities of Colombia. Int J Infect Dis 2014; 19: 67-73.
93. Allegranzi B, Gayet-Ageron A, Damani N, et al. Global implementation of WHO's multimodal strategy for improvement of hand hygiene: A quasi-experimental study. Lancet Infect Dis 2013; 13: 843-51.
94. Pires dos Santos R, Jacoby T, Pires Machado D, et al. Hand hygiene, and not ertapenem use, contributed to reduction of carbapenemresistant Pseudomonas aeruginosa rates. Infect Control Hosp Epidemiol 2011; 32: 584-90.
95. Al-Tawfiq JA, Abed MS, Al-Yami N, Birrer RB. Promoting and sustaining a hospital-wide, multifaceted hand hygiene program resulted in significant reduction in health care-associated infections. Am J Infect Control 2013; 41: 482-6.
96. Beardsley JR, Williamson JC, Johnson JW, Luther VP, Wrenn RH, Ohl CC. Show me the money: Long-term financial impact of an antimicrobial stewardship program. Infect Control Hosp Epidemiol 2012; 33: 398-400.
97. Standiford HC, Chan S, Tripoli M, Weekes E, Forrest GN. Antimicrobial stewardship at a large tertiary care academic medical center: Cost analysis before, during, and after a 7-year program. Infect Control Hosp Epidemiol 2012; 33: 338-45.
98. van de Sande-Bruinsma N, Grundmann H, Verloo D, et al., for the European Antimicrobial Resistance Surveillance System Group, European Surveillance of Antimicrobial Consumption Project Group. Antimicrobial drug use and resistance in Europe. Emerg Infect Dis 2008; 14: 1722-30.
99. Lewis GJ, Fang X, Gooch M, Cook PP. Decreased resistance of Pseudomonas aeruginosa with restriction of ciprofloxacin in a large teaching hospital's intensive care and intermediate care units. Infect Control Hosp Epidemiol 2012; 33: 368-73.
100. WHO. Save Lives: Clean Your Hands-WHO's Annual Campaign. Geneva, Switzerland: World Health Organization; 2014.
101. Head MG, Fitchett JR, Cooke MK,Wurie FB, Hayward AC, Atun R. UK investments in global infectious disease research 1997e2010: A case study. Lancet Infect Dis 2013; 13: 55-64.
102. Rosenthal VD, Maki DG, Graves N. The International Nosocomial Infection Control Consortium (INICC): Goals and objectives, description of surveillance methods, and operational activities. Am J Infect Control 2008; 36: E1-12.
103. Rosenthal VD, Richtmann R, Singh S, et al., for the International Nosocomial Infection Control Consortium. Surgical site infections, International Nosocomial Infection Control Consortium (INICC) report, data summary of 30 countries, 2005e2010. Infect Control Hosp Epidemiol 2013; 34: 597-604.
104. Population Reference Bureau. 2013 World Population Data Sheet. In: USAID; 2013. Available at: Http://www.prb.org/pdf13/2013- population-data-sheet-eng.pdf.
105. Safdar N, Anderson DJ, Braun BI, et al., for the Research Committee of the Society for Healthcare Epidemiology of America. The evolving landscape of healthcare-associated infections: Recent advances in prevention and a road map for research. Infect Control Hosp Epidemiol 2014; 35: 480-93.